Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Novel Laboratories, Inc. d.b.a LUPIN: GaviLyte-C Electrolyte Solution Recalled for Failed Stability Specifications

Agency Publication Date: August 13, 2021
Share:
Sign in to monitor this recall

Summary

Novel Laboratories, Inc. (d.b.a LUPIN) is recalling 20,814 bottles of GaviLyte-C (PEG-3350 and Electrolytes for Oral Solution, USP) with Flavor Pack. This medication, used for bowel cleansing before colonoscopies, was found to be out of specification for osmolarity during stability testing. Consumers who have this specific medication should contact their doctor or pharmacist to discuss alternatives, as the product may not perform as intended.

Risk

The product failed stability tests for osmolarity, meaning the concentration of particles in the solution is incorrect. This imbalance can potentially affect the safety and effectiveness of the bowel preparation process, though no specific injuries have been reported to date.

What You Should Do

  1. Check your medication bottle for the brand name 'GaviLyte-C' (PEG-3350 and Electrolytes for Oral Solution) with NDC 43386-060-19.
  2. Locate the lot number and expiration date on the product label. This recall specifically affects Lot S001133 with an expiration date of 7/2022.
  3. If you possess the affected lot, stop using the product and contact your healthcare provider or pharmacist for guidance on an alternative medication.
  4. Return any unused product to the pharmacy or place of purchase for a refund and contact Lupin Pharmaceuticals for further instructions.
  5. For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

💰Full Refund
How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund.

Affected Products

Product: GaviLyte-C PEG-3350 (240g) and Electrolytes for Oral Solution, USP with Flavor Pack
Model:
NDC 43386-060-19
Recall #: D-0726-2021
Lot Numbers:
S001133 (exp 7/2022)
Date Ranges: exp 7/2022

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 88390
Status: Resolved
Manufacturer: Novel Laboratories, Inc. d.b.a LUPIN
Manufactured In: United States
Units Affected: 20,814 bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.